Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study (Q34147730)

31 July 2017

title

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study (English)

1 reference

31 July 2017

1 reference

Garnet L Anderson

6

0 references

Mark A. Hlatky

object named as

Mark Hlatky

9

0 references

JoAnn E. Manson

8

object named as

Joann E Manson

1 reference

31 July 2017

11

Scott D Ramsey

1 reference

31 July 2017

7

Rowan T Chlebowski

1 reference

31 July 2017

Joshua A Roth

1

1 reference

31 July 2017

Ruth Etzioni

2

1 reference

31 July 2017

Teresa M Waters

3

1 reference

31 July 2017

Mary Pettinger

4

1 reference

31 July 2017

Jacques E Rossouw

5

1 reference

31 July 2017

Karen C Johnson

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

Annals of Internal Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

160

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

594-602

1 reference

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Estimating the NIH efficient frontier

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Expected net present value of sample information: from burden to investment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The 2012 hormone therapy position statement of: The North American Menopause Society

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The social value of a QALY: raising the bar or barring the raise?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Cost-effectiveness of hormone therapy in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The impact of clinical trials on the use of hormone replacement therapy. A population-based study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Assessing the economic impact of chronic conditions in postmenopausal women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Calculation of quality adjusted life years in the published literature: a review of methodology and transparency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The estimation of a preference-based measure of health from the SF-36.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Current perspectives on benefits and risks of hormone replacement therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Handling uncertainty in cost-effectiveness models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The benefits and risks of hormone replacement therapy: An epidemiologic overview

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Hormone therapy to prevent disease and prolong life in postmenopausal women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The use of QALYs in clinical and patient decision-making: issues and prospects.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Do oncologists believe new cancer drugs offer good value?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The value of information and optimal clinical trial design.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Expected value of sample information calculations in medical decision modeling.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The relation between funding by the National Institutes of Health and the burden of disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

Deriving a preference-based single index from the UK SF-36 Health Survey.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157355

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

28 October 2018

1 reference

12 December 2020

Moving the QALY forward: rationale for change

1 reference

12 December 2020

Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the message

1 reference

12 December 2020

Editorial: Moving the QALY forward or just stuck in traffic?

1 reference

12 December 2020

Willingness to pay for a QALY

1 reference

12 December 2020

Utilities and quality-adjusted life years

1 reference

12 December 2020

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3

1 reference

12 December 2020

Identifiers

DOI

10.7326/M13-2348

1 reference

31 July 2017

1 reference

31 July 2017

1 reference